Of chloroquine and COVID-19

doi:10.1016/j.antiviral.2020.104762

Review

. 2020 May:177:104762.

doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.

Of chloroquine and COVID-19

Franck Touret¹, Xavier de Lamballerie²

Affiliations

¹ Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: franck.touret@univ-amu.fr.
² Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: xavier.de-lamballerie@univ-amu.fr.

PMID: 32147496
PMCID: PMC7132364
DOI: 10.1016/j.antiviral.2020.104762

Review

Of chloroquine and COVID-19

Franck Touret et al. Antiviral Res. 2020 May.

. 2020 May:177:104762.

doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.

Authors

Franck Touret¹, Xavier de Lamballerie²

Affiliations

¹ Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: franck.touret@univ-amu.fr.
² Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: xavier.de-lamballerie@univ-amu.fr.

PMID: 32147496
PMCID: PMC7132364
DOI: 10.1016/j.antiviral.2020.104762

Abstract

Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.

Keywords: 2019-nCoV; Antiviral; COVID-19; Chloroquine; SARS-CoV-2.

PubMed Disclaimer

Cited by

The journey of antimalarial drugs against SARS-CoV-2: Review article.
Sarhan AA, Ashour NA, Al-Karmalawy AA. Sarhan AA, et al. Inform Med Unlocked. 2021;24:100604. doi: 10.1016/j.imu.2021.100604. Epub 2021 May 19. Inform Med Unlocked. 2021. PMID: 34028468 Free PMC article. Review.
Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID-19.
Pillat MM, Krüger A, Guimarães LMF, Lameu C, de Souza EE, Wrenger C, Ulrich H. Pillat MM, et al. Cytometry A. 2020 Sep;97(9):872-881. doi: 10.1002/cyto.a.24190. Epub 2020 Aug 21. Cytometry A. 2020. PMID: 32686260 Free PMC article. Review.
Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies.
Costa FF, Rosário WR, Ribeiro Farias AC, de Souza RG, Duarte Gondim RS, Barroso WA. Costa FF, et al. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):809-814. doi: 10.1016/j.dsx.2020.06.016. Epub 2020 Jun 11. Diabetes Metab Syndr. 2020. PMID: 32540733 Free PMC article.
COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics.
Azer SA. Azer SA. New Microbes New Infect. 2020 Sep;37:100738. doi: 10.1016/j.nmni.2020.100738. Epub 2020 Aug 5. New Microbes New Infect. 2020. PMID: 32834902 Free PMC article. Review.
Facing coronavirus disease 2019: What do we know so far? (Review).
Guo Q, Xu W, Wang PF, Ji HY, Zhang XL, Wang K, Li J. Guo Q, et al. Exp Ther Med. 2021 Jun;21(6):658. doi: 10.3892/etm.2021.10090. Epub 2021 Apr 20. Exp Ther Med. 2021. PMID: 33968188 Free PMC article. Review.

See all "Cited by" articles

References

1. Chauhan A., Tikoo A. The enigma of the clandestine association between chloroquine and HIV-1 infection. HIV Med. 2015;16:585–590. doi: 10.1111/hiv.12295. - DOI - PubMed
1. Chinese Clinical Trial Register (ChiCTR) The world health organization international clinical trials registered organization registered platform. http://www.chictr.org.cn/enIndex.aspx accessed 3.1.20.
1. Colson P., Rolain J.-M., Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int. J. Antimicrob. Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105923. 105923. - DOI - PMC - PubMed
1. Connolly K.M., Stecher V.J., Danis E., Pruden D.J., LaBrie T. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs. Agents Actions. 1988;25:94–105. doi: 10.1007/bf01969100. - DOI - PubMed
1. Coombs K., Mann E., Edwards J., Brown D.T. Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus. J. Virol. 1981;37:1060–1065. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- H1 Connect - Access expert opinions and insights on biomedical research.
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
Miscellaneous
- NCI CPTAC Assay Portal

[1] Chauhan A., Tikoo A. The enigma of the clandestine association between chloroquine and HIV-1 infection. HIV Med. 2015;16:585–590. doi: 10.1111/hiv.12295. - DOI - PubMed

[2] Chauhan A., Tikoo A. The enigma of the clandestine association between chloroquine and HIV-1 infection. HIV Med. 2015;16:585–590. doi: 10.1111/hiv.12295. - DOI - PubMed

[3] Chinese Clinical Trial Register (ChiCTR) The world health organization international clinical trials registered organization registered platform. http://www.chictr.org.cn/enIndex.aspx accessed 3.1.20.

[4] Chinese Clinical Trial Register (ChiCTR) The world health organization international clinical trials registered organization registered platform. http://www.chictr.org.cn/enIndex.aspx accessed 3.1.20.

[5] Colson P., Rolain J.-M., Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int. J. Antimicrob. Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105923. 105923. - DOI - PMC - PubMed

[6] Colson P., Rolain J.-M., Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int. J. Antimicrob. Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105923. 105923. - DOI - PMC - PubMed

[7] Connolly K.M., Stecher V.J., Danis E., Pruden D.J., LaBrie T. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs. Agents Actions. 1988;25:94–105. doi: 10.1007/bf01969100. - DOI - PubMed

[8] Connolly K.M., Stecher V.J., Danis E., Pruden D.J., LaBrie T. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs. Agents Actions. 1988;25:94–105. doi: 10.1007/bf01969100. - DOI - PubMed

[9] Coombs K., Mann E., Edwards J., Brown D.T. Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus. J. Virol. 1981;37:1060–1065. - PMC - PubMed

[10] Coombs K., Mann E., Edwards J., Brown D.T. Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus. J. Virol. 1981;37:1060–1065. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Of chloroquine and COVID-19

Affiliations

Of chloroquine and COVID-19

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous